← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 27, 2018Last known activity
Sep 30, 2025
Timeline
2010s
- Jun 1, 2012
Caliway Biopharmaceuticals Co., Ltd.— Founded
Drugs by trial phase (2 distinct, 12 trials)
Phase 3 (2 own, 0 via acquisition)
Recent trials (19)
- NCT07140939OfficialPhase 3Sep 30, 2025
- NCT07140939Lead sponsorPhase 3Sep 30, 2025
- NCT06303570Lead sponsorPhase 2Dec 31, 2024
- NCT06005441Study directorPhase 2Nov 10, 2023
- NCT06005441Lead sponsorPhase 2Nov 10, 2023
- NCT05736107Lead sponsorPhase 2May 30, 2023
- NCT05736107Study directorPhase 2May 30, 2023
- NCT05836779Lead sponsorPhase 2May 10, 2023
- NCT05836779Study directorPhase 2May 10, 2023
- NCT05632926Study directorPhase 2Jan 9, 2023
- NCT05632926Lead sponsorPhase 2Jan 9, 2023
- NCT05387733Lead sponsorPhase 2Oct 3, 2022
- NCT05387733Study directorPhase 2Oct 3, 2022
- NCT05234736Lead sponsorPhase 2Feb 11, 2022
- NCT05234736Study directorPhase 2Feb 11, 2022
Details
- Founded
- Taipei, TW Jun 1, 2012
- Last known activity
- Sep 30, 2025